Renaissance Technologies
ZURA icon

Renaissance Technologies’s Zura Bio ZURA Stock Holding History

Renaissance Technologies’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
321,702
+8,402
+3% +$40K ﹤0.01% 1977
2026
Q1 		$1.86M Buy
313,300
+10,200
+3% +$61.6K ﹤0.01% 1936
2025
Q4 		$1.59M Buy
303,100
+47,700
+19% +$189K ﹤0.01% 2014
2025
Q3 		$1.11M Buy
255,400
+51,267
+25% +$92.2K ﹤0.01% 2430
2025
Q2 		$214K Sell
204,133
-218,090
-52% -$261K ﹤0.01% 3151
2025
Q1 		$545K Buy
422,223
+293,109
+227% +$462K ﹤0.01% 2706
2024
Q4 		$323K Buy
129,114
+65,214
+102% +$232K ﹤0.01% 3011
2024
Q3 		$259K Buy
63,900
+46,500
+267% +$174K ﹤0.01% 3035
2024
Q2 		$60.9K Buy
17,400
+5,900
+51% +$24.1K ﹤0.01% 3261
2024
Q1 		$30K Sell
11,500
-300
-3% -$1.06K ﹤0.01% 3553
2023
Q4 		$55K Buy
+11,800
New +$59K ﹤0.01% 3438

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies's ZURA Position: Q2 2026 in Review

Renaissance Technologies increased its Zura Bio (ZURA) stake by 2.7% in Q2 2026, buying an estimated $40K and bringing the position to 321,702 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

Renaissance Technologies first reported a position in ZURA in Q4 2023 and has held it in 11 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Renaissance Technologies held 321,702 shares of Zura Bio worth $1.9M as of Q2 2026.
  • Renaissance Technologies bought 8,402 Zura Bio shares in Q2 2026, an estimated $40K.
  • Zura Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1977 holding.
  • Renaissance Technologies first reported a position in Zura Bio in Q4 2023 and has held it in 11 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.